Doctor profile · Federal record

Dr. Khaldoun Al-Rayess, MD

Endocrinology, Diabetes & Metabolism Physician (CMS: Internal Medicine) · Endocrinology, Diabetes & Metabolism Physician · Layton, UT

  • NPI 1003808122
  • Accepts Medicare
  • 21 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2121 N 1700 W
Layton, UT 840418803
(801) 773-4840
fax (801) 525-8151
Mailing address
Po Box 337
Layton, UT 840410337

Credentials & registration

NPPES · NUCC
NPI registered
August 2005 — 21 yrs on file
Profile last updated
December 16, 2019
Year of graduation
2005 — 21 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State licenses (2)
Utah #5804089-1205 · Utah #5804089

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1003808122. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
5,614
Distinct HCPCS
10
Medicare allowed
$163,341
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 1,200 15 $23
36415 Insertion of needle into vein for collection of blood sample 541 272 $8
80053 Blood test, comprehensive group of blood chemicals 478 258 $10
84443 Blood test, thyroid stimulating hormone (tsh) 364 218 $16
84439 Thyroxine (thyroid chemical), free 345 204 $9
84481 Thyroid hormone, t3 measurement, free 333 195 $16
99214 Established patient office or other outpatient visit, 30-39 minutes 327 216 $120
83036 Hemoglobin a1c level 323 181 $9
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 271 163 $8
80061 Blood test, lipids (cholesterol and triglycerides) 233 127 $13

In context: peer comparison

Among 2 peers in this city , average services per provider: 172. This provider delivers 33× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,668
Transactions
71
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Corcept Therapeutics 11 $301.87
Lilly USA, LLC 14 $257.27
SANOFI-AVENTIS U.S. LLC 7 $187.89
Xeris Pharmaceuticals, Inc. 7 $150.76
Abbott Laboratories 5 $94.67
Amgen Inc. 4 $81.74
Tandem Diabetes Care, Inc. 5 $81.30
Novo Nordisk Inc 4 $68.53
Chiesi USA, Inc. 3 $64.04
Neurocrine Biosciences, Inc. 2 $51.62
Averitas Pharma Inc. 1 $45.07
Radius Health, Inc. 2 $41.43
Ascensia Diabetes Care Us Inc. 2 $40.09
Kyowa Kirin, Inc. 2 $38.21
Medtronic, Inc. 2 $37.39

By nature of payment

Food and Beverage
$1,668

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,564
Patients
385
Total drug cost
$252,882
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 608 158 $11,653
Liothyronine Sodium Generic 94 30 $5,485
Pravastatin Sodium Generic 88 22 $1,421
Hydrocortisone Generic 86 21 $6,225
Metformin Hcl Er (Metformin Hcl) Brand 85 25 $1,779
Testosterone Cypionate Generic 83 23 $2,731
Metformin Hcl Generic 78 18 $907
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 75 15 $60,535
Novolog Flexpen (Insulin Aspart) Brand 70 13 $85,229
Synthroid (Levothyroxine Sodium) Brand 68 20 $6,787

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Khaldoun Al-Rayess's medical specialty?
Dr. Khaldoun Al-Rayess practices Endocrinology, Diabetes & Metabolism Physician in Layton, UT.
Where does Dr. Khaldoun Al-Rayess practice?
Dr. Khaldoun Al-Rayess practices at 2121 N 1700 W, Layton, UT 840418803. Office phone: 8017734840.
What is Dr. Khaldoun Al-Rayess's NPI?
Dr. Khaldoun Al-Rayess's National Provider Identifier (NPI) is 1003808122, issued by NPPES.
Does Dr. Khaldoun Al-Rayess accept Medicare assignment?
Yes. Dr. Khaldoun Al-Rayess accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Khaldoun Al-Rayess commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Insertion of needle into vein for collection of blood sample (HCPCS 36415); Blood test, comprehensive group of blood chemicals (HCPCS 80053). Source: CMS Medicare Physician & Other Practitioners file.